Developing Novel Therapeutics for HPV-Related Diseases

We develop creatively designed therapeutics that dramatically improve health outcomes for patients suffering from diseases caused by HPV and other viruses.

Antiva in the

August 16, 2018

A Women’s Health Startup Tried to Drum Up Interest for a Much-Needed Drug. Many Men Didn’t Get It Read article (pdf)

July 10, 2018

Antiva Biosciences Closes $15 Million Series C-1 Financing Read more

March 28, 2017

Antiva Biosciences Closes $22 Million Series C Financing Read more